you are here:

Sharon Bio Medicine Ltd.

BSE: 532908 | NSE: SHARONBIO | Series: NA | ISIN: INE028B01029 | SECTOR: Pharmaceuticals

BSE Live

Mar 28, 15:40
3.21 0.00 (0.00%)
Volume
No Data Available
32,550
  • Prev. Close

    3.21

  • Open Price

    3.26

  • Bid Price (Qty.)

    3.10 (100)

  • Offer Price (Qty.)

    3.26 (1000)

Sharon Bio Medicine is not traded on BSE in the last 30 days

NSE Live

Mar 28, 15:31
3.30 0.00 (0.00%)
Volume
No Data Available
8,834
  • Prev. Close

    3.30

  • Open Price

    3.30

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Sharon Bio Medicine is not traded on NSE in the last 30 days

Financials

2020 2019 2018 2017 2016
Yearly Results of Sharon Bio Medicine (in Rs. Cr.) Mar '21 Mar '20 Mar '19 Mar '18 Mar '17  
Net Sales/Income from operations 172.86 171.22 137.33 124.48 138.81  
Other Operating Income -- -- 7.32 3.98 --  
Total Income From Operations 172.86 171.22 144.65 128.46 138.81  
EXPENDITURE  
Consumption of Raw Materials 91.74 83.37 75.05 63.66 78.43  
Purchase of Traded Goods -- -- -- -- --  
Increase/Decrease in Stocks -5.46 0.89 -8.12 1.09 158.96  
Power & Fuel -- -- -- -- --  
Employees Cost 30.52 29.20 25.74 22.63 21.29  
Depreciation 11.51 11.06 11.17 10.67 16.12  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 34.44 31.36 30.81 36.89 45.33  
P/L Before Other Inc. , Int., Excpt. Items & Tax 10.12 15.34 10.00 -6.48 -181.33  
Other Income 4.11 1.79 2.36 2.11 19.85  
P/L Before Int., Excpt. Items & Tax 14.22 17.13 12.36 -4.37 -161.47  
Interest 0.17 0.22 -- -- 29.87  
P/L Before Exceptional Items & Tax 14.05 16.91 12.36 -4.37 -191.34  
Exceptional Items -- -- -1.10 -96.93 -154.18  
P/L Before Tax 14.05 16.91 11.26 -101.30 -345.52  
Tax -- -- -- -- 2.34  
P/L After Tax from Ordinary Activities 14.05 16.91 11.26 -101.30 -347.86  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 14.05 16.91 11.26 -101.30 -347.86  
Equity Share Capital 1.15 23.79 23.79 23.79 23.79  
Reserves Excluding Revaluation Reserves -626.62 -663.54 -648.25 -659.02 -558.02  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 24.41 1.42 0.96 -8.49 -29.25  
Diluted EPS 24.41 1.42 0.96 -8.49 -29.25  
EPS After Extra Ordinary  
Basic EPS. 24.41 1.42 0.96 -8.49 -29.25  
Diluted EPS. 24.41 1.42 0.96 -8.49 -29.25  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited